Asensus Surgical Inc (ASXC)
0.26
0.00 (0.00%)
USD |
NYAM |
May 17, 16:00
0.2593
0.00 (0.00%)
After-Hours: 20:00
Asensus Surgical Research and Development Expense (Annual): 37.02M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.02M |
| December 31, 2022 | 28.94M |
| December 31, 2021 | 19.35M |
| December 31, 2020 | 16.62M |
| December 31, 2019 | 22.47M |
| December 31, 2018 | 21.82M |
| December 31, 2017 | 21.99M |
| December 31, 2016 | 29.27M |
| December 31, 2015 | 29.67M |
| December 31, 2014 | 27.94M |
| December 31, 2013 | 12.70M |
| December 31, 2012 | 6.283M |
| December 31, 2011 | 3.367M |
| December 31, 2010 | 2.728M |
| December 31, 2009 | 1.256M |
| Date | Value |
|---|---|
| December 31, 2008 | 2.682M |
| December 31, 2007 | 1.636M |
| December 31, 2006 | 0.739M |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | 1.522M |
| December 31, 2001 | 1.841M |
| December 31, 2000 | 1.48M |
| December 31, 1999 | 1.60M |
| December 31, 1998 | 4.50M |
| December 31, 1997 | 8.10M |
| December 31, 1996 | 5.50M |
| December 31, 1995 | 3.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
16.62M
Minimum
2020
37.02M
Maximum
2023
24.88M
Average
22.47M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Glaukos Corp | 138.77M |
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |